Summary
Global Markets Direct’s, ‘Ache Laboratorios Farmaceuticos S/A - Product Pipeline Review - 2016’, provides an overview of the Ache Laboratorios Farmaceuticos S/A’s pharmaceutical research and development focus.
The report provides comprehensive information on the therapeutics under development by Ache Laboratorios Farmaceuticos S/A, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.
Scope
- The report provides a snapshot of the pipeline therapeutic landscape of Ache Laboratorios Farmaceuticos S/A
- The report provides overview of Ache Laboratorios Farmaceuticos S/A including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Ache Laboratorios Farmaceuticos S/A’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Ache Laboratorios Farmaceuticos S/A’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
- Evaluate Ache Laboratorios Farmaceuticos S/A’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Ache Laboratorios Farmaceuticos S/A
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Ache Laboratorios Farmaceuticos S/A’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Ache Laboratorios Farmaceuticos S/A Snapshot 5
Ache Laboratorios Farmaceuticos S/A Overview 5
Key Information 5
Key Facts 5
Ache Laboratorios Farmaceuticos S/A - Research and Development Overview 6
Key Therapeutic Areas 6
Ache Laboratorios Farmaceuticos S/A - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Combination Treatment Modalities 10
Ache Laboratorios Farmaceuticos S/A - Pipeline Products Glance 11
Ache Laboratorios Farmaceuticos S/A - Late Stage Pipeline Products 11
Phase III Products/Combination Treatment Modalities 11
Ache Laboratorios Farmaceuticos S/A - Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
Ache Laboratorios Farmaceuticos S/A - Early Stage Pipeline Products 14
Preclinical Products/Combination Treatment Modalities 14
Discovery Products/Combination Treatment Modalities 15
Ache Laboratorios Farmaceuticos S/A - Drug Profiles 16
ACH-09 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
(adapalene + benzoyl peroxide) 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
ACH-24 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
ACH-04 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
ACH-15 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
ACH-36 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
AG-01 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
AZ-02 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
AZ-03 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
AZ-04 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Ache Laboratorios Farmaceuticos S/A - Pipeline Analysis 26
Ache Laboratorios Farmaceuticos S/A - Pipeline Products by Target 26
Ache Laboratorios Farmaceuticos S/A - Pipeline Products by Route of Administration 27
Ache Laboratorios Farmaceuticos S/A - Pipeline Products by Molecule Type 28
Ache Laboratorios Farmaceuticos S/A - Pipeline Products by Mechanism of Action 29
Ache Laboratorios Farmaceuticos S/A - Dormant Projects 30
Ache Laboratorios Farmaceuticos S/A - Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Appendix 32
Methodology 32
Coverage 32
Secondary Research 32
Primary Research 32
Expert Panel Validation 32
Contact Us 32
Disclaimer 33
List of Tables
Ache Laboratorios Farmaceuticos S/A, Key Information 5
Ache Laboratorios Farmaceuticos S/A, Key Facts 5
Ache Laboratorios Farmaceuticos S/A - Pipeline by Indication, 2016 7
Ache Laboratorios Farmaceuticos S/A - Pipeline by Stage of Development, 2016 8
Ache Laboratorios Farmaceuticos S/A - Monotherapy Products in Pipeline, 2016 9
Ache Laboratorios Farmaceuticos S/A - Combination Treatment Modalities in Pipeline, 2016 10
Ache Laboratorios Farmaceuticos S/A - Phase III, 2016 11
Ache Laboratorios Farmaceuticos S/A - Phase II, 2016 12
Ache Laboratorios Farmaceuticos S/A - Phase I, 2016 13
Ache Laboratorios Farmaceuticos S/A - Preclinical, 2016 14
Ache Laboratorios Farmaceuticos S/A - Discovery, 2016 15
Ache Laboratorios Farmaceuticos S/A - Pipeline by Target, 2016 26
Ache Laboratorios Farmaceuticos S/A - Pipeline by Route of Administration, 2016 27
Ache Laboratorios Farmaceuticos S/A - Pipeline by Molecule Type, 2016 28
Ache Laboratorios Farmaceuticos S/A - Pipeline Products by Mechanism of Action, 2016 29
Ache Laboratorios Farmaceuticos S/A - Dormant Developmental Projects,2016 30
Ache Laboratorios Farmaceuticos S/A, Subsidiaries 31
List of Figures
Ache Laboratorios Farmaceuticos S/A - Pipeline by Top 10 Indication, 2016 7
Ache Laboratorios Farmaceuticos S/A - Pipeline by Stage of Development, 2016 8
Ache Laboratorios Farmaceuticos S/A - Monotherapy Products in Pipeline, 2016 9
Ache Laboratorios Farmaceuticos S/A - Pipeline by Target, 2016 26
Ache Laboratorios Farmaceuticos S/A - Pipeline by Route of Administration, 2016 27
Ache Laboratorios Farmaceuticos S/A - Pipeline by Molecule Type, 2016 28
Ache Laboratorios Farmaceuticos S/A - Pipeline Products by Mechanism of Action, 2016 29
